Published in J Immunol on August 15, 1999
Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ (2000) 5.42
Paediatric tuberculosis. Lancet Infect Dis (2008) 3.97
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol (2008) 2.27
Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants. J Infect Dis (2014) 2.21
Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice. Vaccine (2009) 2.12
Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial. J Infect Dis (2014) 1.73
Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood (2006) 1.65
Development of interleukin-12-producing capacity throughout childhood. Infect Immun (2002) 1.65
T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol (2005) 1.50
Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine (2009) 1.45
Campbell De Morgan's 'Observations on cancer', and their relevance today. J R Soc Med (2002) 1.44
Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun (2001) 1.44
Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun (2003) 1.44
Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology (2002) 1.39
Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods (2010) 1.35
Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res (2009) 1.33
Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol (2006) 1.26
Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle. Clin Exp Immunol (2005) 1.23
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22
Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect Immun (2000) 1.22
BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis (2011) 1.21
Immune biology of macaque lymphocyte populations during mycobacterial infection. Clin Exp Immunol (2003) 1.20
Safety and efficacy of neonatal vaccination. Eur J Immunol (2009) 1.17
Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults. J Virol (2002) 1.17
T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol (2002) 1.12
Novel human in vitro system for evaluating antimycobacterial vaccines. Infect Immun (2004) 1.10
Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol (2015) 1.10
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A (2008) 1.08
In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS (2014) 1.07
Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding. J Virol (2007) 1.04
Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: a randomized controlled trial in Papua New Guinea. Vaccine (2009) 1.04
Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin Exp Immunol (2005) 1.03
Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect Immun (2006) 1.03
BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology (2007) 1.03
Immunology of pediatric HIV infection. Immunol Rev (2013) 1.02
Effects of antenatal and postnatal environments on CD4 T-cell responses to Mycobacterium bovis BCG in healthy infants in the Gambia. Clin Vaccine Immunol (2008) 1.01
Protective efficacy of anti-Helicobacter pylori immunity following systemic immunization of neonatal mice. Infect Immun (2003) 1.01
Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. J Infect Dis (2010) 1.00
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques. J Virol (2010) 0.99
Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish. Clin Vaccine Immunol (2011) 0.98
Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants. PLoS One (2008) 0.98
Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol (2008) 0.97
CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells. PLoS One (2014) 0.93
Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus. J Virol (2002) 0.93
A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques. Clin Vaccine Immunol (2012) 0.93
Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin Vaccine Immunol (2007) 0.93
Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination. Clin Exp Immunol (2012) 0.92
Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment. PLoS One (2010) 0.92
Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates. Clin Vaccine Immunol (2006) 0.90
Impaired gamma interferon responses against parvovirus B19 by recently infected children. J Virol (2000) 0.90
A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guérin immunisation in children and adults. PLoS One (2012) 0.89
Murine neonates are highly resistant to Yersinia enterocolitica following orogastric exposure. Infect Immun (2007) 0.89
Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination. Front Immunol (2015) 0.89
99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: the role of infections in allergy: atopic asthma as a paradigm. Clin Exp Immunol (2010) 0.89
Targeting regulatory T cells to improve vaccine immunogenicity in early life. Front Microbiol (2014) 0.88
Effective vaccination against tuberculosis-a new ray of hope. Clin Exp Immunol (2000) 0.87
Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis. Clin Exp Immunol (2005) 0.86
Immunisation of premature infants. Arch Dis Child (2006) 0.86
Newborn mice vaccination with BCG.HIVA²²² + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes. Clin Dev Immunol (2011) 0.86
In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals. Clin Vaccine Immunol (2007) 0.85
The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants. PLoS One (2013) 0.84
A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol (2009) 0.84
Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG. PLoS One (2012) 0.84
Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK. BMC Infect Dis (2014) 0.83
Vaccination strategies to reduce the risk of leukaemia and melanoma. J R Soc Med (2003) 0.81
An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice. J Virol (2014) 0.80
Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonates. Infect Immun (2010) 0.80
Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization. Clin Perinatol (2010) 0.80
Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth. Clin Dev Immunol (2010) 0.80
Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG. Mol Ther Methods Clin Dev (2014) 0.79
Flow cytometric detection of gamma interferon can effectively discriminate Mycobacterium bovis BCG-vaccinated cattle from M. bovis-infected cattle. Clin Vaccine Immunol (2006) 0.79
Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation. PLoS One (2007) 0.79
A Model to Explain How the Bacille Calmette Guérin (BCG) Vaccine Drives Interleukin-12 Production in Neonates. PLoS One (2016) 0.79
Exploring the origins of asthma: Lessons from twin studies. Eur Clin Respir J (2014) 0.78
The neonatal susceptibility window for inhalant allergen sensitization in the atopically predisposed canine asthma model. Immunology (2013) 0.78
Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial. Trials (2015) 0.78
Neonatal Vaccination: Challenges and Intervention Strategies. Neonatology (2016) 0.77
Neonatal vaccination with bacille Calmette-Guérin promotes the dendritic development of hippocampal neurons. Hum Vaccin Immunother (2015) 0.77
Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns. Pediatr Res (2017) 0.76
Preclinical Development of BCG.HIVA(2auxo.int), Harboring an Integrative Expression Vector, for a HIV-TB Pediatric vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity. Hum Vaccin Immunother (2017) 0.76
Clinical and immunological evaluation after BCG-id vaccine in leprosy patients in a 5-year follow-up study. J Inflamm Res (2012) 0.76
Concomitant administration of Mycobacterium bovis BCG with the meningococcal C conjugate vaccine to neonatal mice enhances antibody response and protective efficacy. Clin Vaccine Immunol (2011) 0.76
Delayed BCG vaccination results in minimal alterations in T cell immunogenicity of acellular pertussis and tetanus immunizations in HIV-exposed infants. Vaccine (2015) 0.76
Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model. PLoS One (2015) 0.75
In vitro gene expression profile of bovine peripheral blood mononuclear cells in early Mycobacterium bovis infection. Exp Ther Med (2015) 0.75
Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? Front Immunol (2017) 0.75
Immune approaches for the prevention of breast milk transmission of HIV-1. Adv Exp Med Biol (2012) 0.75
An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark. Respir Res (2002) 0.75
Effect of maternal immune status on responsiveness of bacillus calmette-gurin vaccination in mouse neonates. Osong Public Health Res Perspect (2012) 0.75
Study of the BCG Vaccine-Induced Cellular Immune Response in Schoolchildren in Antananarivo, Madagascar. PLoS One (2015) 0.75
What Have We Learnt about BCG Vaccination in the Last 20 Years? Front Immunol (2017) 0.75
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination. Front Immunol (2017) 0.75
Unique aspects of the perinatal immune system. Nat Rev Immunol (2017) 0.75
A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus. Hum Vaccin Immunother (2017) 0.75
Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG. Med Microbiol Immunol (2013) 0.75
Simple sample size calculation for cluster-randomized trials. Int J Epidemiol (1999) 10.46
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
The Danish National Birth Cohort--its background, structure and aim. Scand J Public Health (2001) 6.09
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ (2000) 5.42
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med (1995) 5.22
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol (2003) 4.66
Measles and atopy in Guinea-Bissau. Lancet (1996) 4.03
Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ (1990) 3.84
Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J (1988) 3.77
Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis (2001) 3.75
Analysis of survival data by the proportional odds model. Stat Med (1984) 3.70
Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect Immun (1989) 3.64
Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br J Anaesth (1992) 3.50
Exposure to measles in utero and Crohn's disease: Danish register study. BMJ (1998) 3.48
APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A (2000) 3.41
A trial of artemether or quinine in children with cerebral malaria. N Engl J Med (1996) 3.28
Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet (1995) 3.20
Meiotic pachytene arrest in MLH1-deficient mice. Cell (1996) 3.18
Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun (1998) 3.14
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
High incidence of malaria in alpha-thalassaemic children. Nature (1996) 3.12
Crop management and agronomic context of the Farm Scale Evaluations of genetically modified herbicide-tolerant crops. Philos Trans R Soc Lond B Biol Sci (2003) 3.12
Mobility and the spread of human immunodeficiency virus into rural areas of West Africa. Int J Epidemiol (2003) 3.06
Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med (1978) 3.00
Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol (2005) 2.97
Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg (1992) 2.96
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG. Microb Pathog (1987) 2.66
Accreditation in transoesophageal echocardiography: statement from the Association of Cardiothoracic Anaesthetists and the British Society of Echocardiography Joint TOE Accreditation Committee. Br J Anaesth (2003) 2.64
In-vitro production of TNF-alpha in blood samples. Lancet (1990) 2.63
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab (2001) 2.61
Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa. Lancet (1997) 2.50
Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med (1976) 2.45
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother (1993) 2.40
Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis (1993) 2.36
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res (2000) 2.36
Is there an acute-phase response in steady-state sickle cell disease? Lancet (1993) 2.35
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS (1998) 2.35
Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa. Lancet (1989) 2.33
Improving the transition between paediatric and adult healthcare: a systematic review. Arch Dis Child (2011) 2.33
Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet (1995) 2.29
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol (1998) 2.20
T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun (1994) 2.18
Mobile phone technology in the management of asthma. J Telemed Telecare (2005) 2.15
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia. Aliment Pharmacol Ther (2013) 2.13
The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg (1997) 2.12
Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries. Am J Epidemiol (1999) 2.12
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 2.12
Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health (1997) 2.09
Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. Trans R Soc Trop Med Hyg (1999) 2.08
Interleukin-10 production during septicaemia. Lancet (1994) 2.05
Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice. J Exp Med (1979) 2.03
An epidemic in the field? Rapid assessment procedures and health research. Soc Sci Med (1992) 2.01
Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol (1985) 2.01
Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal. Am J Epidemiol (1997) 1.99
Disordered eating attitudes and behaviours in teenaged girls: a school-based study. CMAJ (2001) 1.98
Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature (1980) 1.97
Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol (2001) 1.96
Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol (1994) 1.92
Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J Clin Invest (1978) 1.90
Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol (1999) 1.90
Human and bovine tuberculosis in the Monze District of Zambia--a cross-sectional study. Br Vet J (1996) 1.88
Overcrowding and intensive exposure as determinants of measles mortality. Am J Epidemiol (1984) 1.85
The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia. Trans R Soc Trop Med Hyg (1996) 1.84
Rapid detection of methicillin-resistant staphylococci by multiplex PCR. J Hosp Infect (1999) 1.84
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine (1997) 1.83
Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg (1995) 1.83
Malaria prevalence is inversely related to vector density in The Gambia, West Africa. Trans R Soc Trop Med Hyg (1995) 1.82
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res (1980) 1.82
T-lymphocyte subsets in West African children: impact of age, sex, and season. J Pediatr (1997) 1.82
High mortality despite good care-seeking behaviour: a community study of childhood deaths in Guinea-Bissau. Bull World Health Organ (1997) 1.80
Determinants of measles mortality in a rural area of Guinea-Bissau: crowding, age, and malnutrition. J Trop Pediatr (1984) 1.79
Enhanced tuberculosis identification through 1-month follow-up of smear-negative tuberculosis suspects. Int J Tuberc Lung Dis (2011) 1.79
Maternal mortality in Guinea-Bissau: the use of verbal autopsy in a multi-ethnic population. Int J Epidemiol (1999) 1.77
Risk factors for diarrheal disease incidence in early childhood: a community cohort study from Guinea-Bissau. Am J Epidemiol (1997) 1.75
Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun (2001) 1.74
Survival among motherless children in rural and urban areas in Guinea-Bissau. Acta Paediatr (2004) 1.73
Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial. AIDS (1997) 1.73
Investigation of under-ascertainment in epidemiological studies based in general practice. Int J Epidemiol (1999) 1.73
A template for improved prevention and control of cardiovascular disease in sub-Saharan Africa. Health Policy Plan (2001) 1.69
Heterogeneity of human serum amyloid A proteins. J Exp Med (1980) 1.68
Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. Arch Dis Child (1990) 1.68
Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia. Trop Med Int Health (1997) 1.65
Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis (1996) 1.64
Lack of association between maternal antibody and protection of African infants from malaria infection. Infect Immun (2000) 1.64